NCT07049198

Brief Summary

People with transfemoral amputation face challenges such as gait asymmetry, instability, and increased energy consumption due to loss of the knee joint. Because of the loss of proprioceptive feedback from their missing limbs, visual feedback is essential for gait correction. Additionally, current visual feedback systems lack portability, cost-effectiveness, and they fail to provide precise, intuitive feedback on spatiotemporal parameters, joint angles, and both frontal and sagittal plane information, limiting their effectiveness in correcting gait abnormalities.This study aims to investigate whether gait training using a real-time 2D motion capture and visual feedback gait training system (2DMV) can improve the gait biomechanics and psychosocial functions of people with unilateral transfemoral amputation (uTFA). The 2DMV system analyzes spatiotemporal parameters and joint kinematics during gait and displays the uTFA's image on a screen, providing visual feedback specifically targeting gait abnormalities. This allows individuals with uTFA to intuitively understand the feedback and make real-time gait adjustments. The biomechanical parameters include joint kinematics, gait symmetry, and walking performance.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Jul 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Jul 2025Jul 2027

First Submitted

Initial submission to the registry

May 13, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 3, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

July 15, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2027

Expected
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

July 3, 2025

Status Verified

July 1, 2025

Enrollment Period

2 years

First QC Date

May 13, 2025

Last Update Submit

July 1, 2025

Conditions

Outcome Measures

Primary Outcomes (11)

  • Step width ratio

    Step width ratio is calculated by dividing step width by pelvis width (step width/pelvis width), and the normal range is between 0.4 to 1.1.

    The step width ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Step length ratio

    Step length ratio is calculated by dividing the step length of the amputated limb by the step length of the non-amputated limb (a value closer to 1 indicate more symmetry, the step length of amputated limb is calculated as the distance between the heel of the non-amputated limb when initial contact and the heel of the amputated limb when initial contact; the step length of non-amputated limb is calculated as the distance between the heel of the amputated limb when initial contact and the heel of the non-amputated limb when initial contact)

    The step length ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Stride time ratio

    Stride time ratio is calculated by dividing the stride time of the amputated limb by the stride time of the non-amputated limb (a value closer to 1 indicates more symmetry, the stride time of the amputated limb is calculated as the time from initial contact of the amputated limb to next initial contact of the same limb; the stride time of the non-amputated limb is calculated as the time from initial contact of the non-amputated limb to next initial contact of the same limb).

    The stride time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Stance time ratio

    Stance time ratio is calculated by dividing the stance time of the amputated limb by the stance time of the non-amputated limb (a value closer to 1 indicates more symmetry, the stance time is calculated from initial contact to toe off of the same limb).

    The stance time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Swing time ratio

    Swing time ratio is calculated by dividing the swing time of the amputated limb by the swing time of the non-amputated limb (a value closer to 1 indicates more symmetry, the swing time is calculated from toe off to initial contact of the same limb).

    The swing time ratio will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Hip extension angle

    The hip extension angle is measured in the sagittal plane during terminal stance.

    The hip extension angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Hip flexion angle

    The hip flexion angle is measured in the sagittal plane at the maximum angle of hip flexion during the swing phase.

    The hip flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Trunk extension and flexion angle

    The trunk extension and flexion angle is measured in the sagittal plane at the initial contact and terminal stance.

    The trunk extension and flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Hip adduction and abduction angle

    The hip adduction and abduction angle is measured in the coronal plane at the maximum angle of hip adduction or abduction angle during the swing phase.

    The hip adduction and abduction angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Horizontal pelvis tilt angle

    The horizontal pelvis tilt angle is measured in the coronal plane at the maximum pelvis tilt angle during single-leg stance.

    The horizontal pelvis tilt angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Trunk lateral flexion angle

    The trunk lateral flexion angle is measured in the coronal plane during midstance.

    The trunk lateral flexion angle will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

Secondary Outcomes (4)

  • The Component Timed-Up-and-Go test, cTUG

    The Component Timed-Up-and-Go test will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • Gait speed

    The gait speed will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • The Activities-specific Balance Confidence Scale, ABC scale

    The Activities-specific Balance Confidence Scale will be measured at Day 1, before the 1st intervention session, and after the 12th intervention session.

  • The National Aeronautics and Space Administration Task Load Index, NASA-TLX

    The National Aeronautics and Space Administration Task Load Index will be measured after the 12th intervention session.

Study Arms (2)

Real-time 2D motion capture and visual feedback system gait training group (VF)

EXPERIMENTAL

The VF group, the 2D motion capture and visual feedback training group, received an intervention consisting of 10 minutes of strength training followed by 30 minutes of visual feedback gait training using the 2DMV system.

Device: Real-time 2D motion capture and visual feedback system gait training

Conventional physical therapy group (PT)

ACTIVE COMPARATOR

The PT group, the conventional physical therapy group, received an intervention consisting of 10 minutes of strength training followed by 30 minutes of gait training without the use of the 2DMV system for visual feedback. During gait training, the therapist provided standard gait correction feedback typically used in conventional physical therapy.

Other: Conventional physical therapy group

Interventions

The difference between the VF group and the PT group lies in the use of real-time visual feedback during gait training; the VF group receives real-time visual feedback, while the PT group undergoes gait training without visual feedback.

Real-time 2D motion capture and visual feedback system gait training group (VF)

Ten minutes of strength training followed by thirty minutes of gait training, during which the 2DMV system is not used to provide visual feedback. During the gait training, the therapist provides gait correction feedback typically used in conventional physical therapy.

Conventional physical therapy group (PT)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years
  • Individuals with unilateral transfemoral amputation or knee disarticulation
  • Wear a prosthesis for at least 3 hours per day
  • Have been using a prosthesis for more than 6 months
  • Medicare Functional Classification Level (K-level) of 2 or above
  • Able to walk independently for 5 meters without assistive devices
  • No pain caused by poor prosthetic fit
  • Montreal Cognitive Assessment Taiwan Version (MoCA-T) score ≥ 26

You may not qualify if:

  • Uncontrolled systemic diseases (e.g., diabetes mellitus, hypertension)
  • Cardiopulmonary or cardiovascular diseases (e.g., heart failure, severe asthma)
  • History of neurological conditions that affect movement (e.g., stroke, spinal cord injury, cerebellar injury)
  • Vestibular disorders
  • Severe osteoporosis
  • Other musculoskeletal injuries or open wounds
  • Epilepsy
  • Uncorrected visual impairments
  • Congenital limb deficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Yang Ming Chiao Tung University

Taipei, 112, Taiwan

Location

Related Links

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 13, 2025

First Posted

July 3, 2025

Study Start

July 15, 2025

Primary Completion (Estimated)

July 10, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

July 3, 2025

Record last verified: 2025-07

Locations